Lanxess (LXS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
19 Mar, 2026Executive summary
Full-year 2025 EBITDA pre exceptionals reached €510 million, down 17% year-over-year, in line with guidance, as Q4 earnings declined sharply due to lower volumes, adverse FX, and the sale of the Urethane Systems business.
Revenue declined 10.9% to €5.673 billion in 2025 amid weak demand and geopolitical uncertainty.
Net financial debt reduced to €2.023 billion by year-end, supported by disciplined working capital management and proceeds from the Urethane Systems sale.
The company exited polymer businesses, focusing on core segments, and initiated permanent cost reductions of €100 million, including 550 job cuts by 2028.
A stable dividend of €0.10 per share is proposed for 2025, maintaining focus on deleveraging.
Financial highlights
Q4 2025 sales were €1,268 million (-14% yoy), with EBITDA pre at €102 million (-36% yoy) and margin at 8.0%.
FY 2025 sales reached €5,673 million (-11% yoy), EBITDA pre exceptionals at €510 million (-16.9% yoy), and margin at 9.0%.
Net income for FY 2025 was -€577 million, impacted by €341 million in impairments.
Free cash flow for FY 2025 was -€30 million, reflecting lower operating results and higher D&A.
Equity ratio remains strong at 45% despite a decrease in total assets and equity.
Outlook and guidance
2026 EBITDA pre exceptionals guidance is set at €450–550 million, reflecting high market volatility and macroeconomic uncertainties.
Cost savings of €150 million targeted by end of 2028, with €100 million by end of 2025.
Business recovery is anticipated no earlier than the second half of 2026, with some positive impulses expected from infrastructure stimulus.
Construction sector recovery is expected earliest in H2 2026; cautious outlook for agro demand.
Free cash flow for 2026 is possible within the guidance range, excluding working capital swings.
Latest events from Lanxess
- Q2 2026 saw strong sales and EBITDA growth, positive cash flow, and guidance reaffirmed.LXS
Q2 2026 (Media) - Q2 2026 delivered higher sales, strong EBITDA, and positive cash flow, but net income stayed negative.LXS
Q2 2026 - Sales and earnings fell, but debt reduction, restructuring, and sustainability drive resilience.LXS
AGM 2026 - Sales and EBITDA fell sharply, but full-year guidance is maintained amid persistent market headwinds.LXS
Q1 2026 (Media) - Sales and EBITDA dropped, but full-year guidance is confirmed and Q2 is set to improve.LXS
Q1 2026 - Sales and EBITDA fell, debt reduced, and EUR 100M cost savings with 550 job cuts announced.LXS
Q4 2025 (Media) - Sales and EBITDA fell sharply in Q3 2025, with cost actions and divestments improving leverage.LXS
Q3 2025 - Earnings rose, costs fell, and sustainability advanced amid global uncertainty and strategic refocus.LXS
AGM 2025 - EBITDA pre rose 32% to €133m, guidance held, and Urethane sale proceeds to reduce debt.LXS
Q1 2025